Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Vogt-Koyanagi-Harada disease can develop during interferon therapy for chronic hepatitis C.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Unconventional lymphocytes are important for quick immune responses and healing of skin and mucosal barriers.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

Applying a DNA vaccine to skin with active hair growth boosts immune response and protection against anthrax in mice.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

TRP channels in the skin are important for sensation and health, and targeting them could help treat skin disorders.

Stress increases nerve fibers and immune cell activity in mouse skin, possibly worsening skin conditions.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

Type I interferons play a key role in the development of various skin diseases.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Leptin, a hormone from fat cells, affects immune responses and can influence skin diseases and hair growth.

Burn scars heal abnormally and more research is needed to find better treatments.

Adding L-glutamine to the diet of Hanwoo steers may boost their immune system and help them cope with heat.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

New treatments and strategies are needed for Alopecia Areata, focusing on immune response and better trial designs.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Aging reduces skin cell renewal and defense against germs due to TGFbeta, but blocking TGFbeta could help restore these functions.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

Special immune cells called Tregs can help prevent lung scarring by blocking a specific growth factor.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

The document concludes that there is a significant lack of reporting on the sex and age of cells in skin research, which could affect clinical trials and treatments.

308-nm excimer light therapy helped over a third of treatment-resistant alopecia universalis patients regrow most of their hair.

Hyaluronic acid and polycaprolactone improve skin regeneration, with polycaprolactone having a stronger effect on healing and tissue repair.

ULBP3 levels are higher in Tinea capitis patients and may help predict the disease's severity.

New treatments and diagnostic methods for various animal skin conditions showed promising results.